235 related articles for article (PubMed ID: 24361713)
21. Measurements of β-arrestin recruitment to activated seven transmembrane receptors using enzyme complementation.
Bassoni DL; Raab WJ; Achacoso PL; Loh CY; Wehrman TS
Methods Mol Biol; 2012; 897():181-203. PubMed ID: 22674166
[TBL] [Abstract][Full Text] [Related]
22. Beta-arrestin signaling and regulation of transcription.
Ma L; Pei G
J Cell Sci; 2007 Jan; 120(Pt 2):213-8. PubMed ID: 17215450
[TBL] [Abstract][Full Text] [Related]
23. Measurement of β-Arrestin Recruitment at GPCRs Using the Tango Assay.
Laroche G; Giguère PM
Methods Mol Biol; 2019; 1947():257-267. PubMed ID: 30969421
[TBL] [Abstract][Full Text] [Related]
24. The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G protein-coupled receptors.
Oakley RH; Hudson CC; Cruickshank RD; Meyers DM; Payne RE; Rhem SM; Loomis CR
Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):21-30. PubMed ID: 15090153
[TBL] [Abstract][Full Text] [Related]
25. Cell-based assays and animal models for GPCR drug screening.
Takakura H; Hattori M; Tanaka M; Ozawa T
Methods Mol Biol; 2015; 1272():257-70. PubMed ID: 25563190
[TBL] [Abstract][Full Text] [Related]
26. New Insights into Arrestin Recruitment to GPCRs.
Spillmann M; Thurner L; Romantini N; Zimmermann M; Meger B; Behe M; Waldhoer M; Schertler GFX; Berger P
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668755
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of neuropeptide Y receptor association with beta-arrestin2 measured by bimolecular fluorescence complementation.
Kilpatrick LE; Briddon SJ; Hill SJ; Holliday ND
Br J Pharmacol; 2010 Jun; 160(4):892-906. PubMed ID: 20438572
[TBL] [Abstract][Full Text] [Related]
28. A high-throughput screening system for G-protein-coupled receptors using β-lactamase enzyme complementation technology.
ZHAO CK; YIN Q; LI SY
Acta Pharmacol Sin; 2010 Dec; 31(12):1618-24. PubMed ID: 21102483
[TBL] [Abstract][Full Text] [Related]
29. High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay.
Hamdan FF; Audet M; Garneau P; Pelletier J; Bouvier M
J Biomol Screen; 2005 Aug; 10(5):463-75. PubMed ID: 16093556
[TBL] [Abstract][Full Text] [Related]
30. A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation.
Barak LS; Ferguson SS; Zhang J; Caron MG
J Biol Chem; 1997 Oct; 272(44):27497-500. PubMed ID: 9346876
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13.
Jenkins L; Brea J; Smith NJ; Hudson BD; Reilly G; Bryant NJ; Castro M; Loza MI; Milligan G
Biochem J; 2010 Dec; 432(3):451-9. PubMed ID: 20919992
[TBL] [Abstract][Full Text] [Related]
32. Multiplexed assays by high-content imaging for assessment of GPCR activity.
Ross DA; Lee S; Reiser V; Xue J; Alves K; Vaidya S; Kreamer A; Mull R; Hudak E; Hare T; Detmers PA; Lingham R; Ferrer M; Strulovici B; Santini F
J Biomol Screen; 2008 Jul; 13(6):449-55. PubMed ID: 18519922
[TBL] [Abstract][Full Text] [Related]
33. A novel luminescence-based β-arrestin recruitment assay for unmodified receptors.
Hauge Pedersen M; Pham J; Mancebo H; Inoue A; Asher WB; Javitch JA
J Biol Chem; 2021; 296():100503. PubMed ID: 33684444
[TBL] [Abstract][Full Text] [Related]
34. Membrane phosphoinositides regulate GPCR-β-arrestin complex assembly and dynamics.
Janetzko J; Kise R; Barsi-Rhyne B; Siepe DH; Heydenreich FM; Kawakami K; Masureel M; Maeda S; Garcia KC; von Zastrow M; Inoue A; Kobilka BK
Cell; 2022 Nov; 185(24):4560-4573.e19. PubMed ID: 36368322
[TBL] [Abstract][Full Text] [Related]
35. Monitoring agonist-promoted conformational changes of beta-arrestin in living cells by intramolecular BRET.
Charest PG; Terrillon S; Bouvier M
EMBO Rep; 2005 Apr; 6(4):334-40. PubMed ID: 15776020
[TBL] [Abstract][Full Text] [Related]
36. A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-arrestin recruitment.
Hanson BJ; Wetter J; Bercher MR; Kopp L; Fuerstenau-Sharp M; Vedvik KL; Zielinski T; Doucette C; Whitney PJ; Revankar C
J Biomol Screen; 2009 Aug; 14(7):798-810. PubMed ID: 19531663
[TBL] [Abstract][Full Text] [Related]
37. Improved Split TEV GPCR β-arrestin-2 Recruitment Assays via Systematic Analysis of Signal Peptide and β-arrestin Binding Motif Variants.
Wu Y; von Hauff IV; Jensen N; Rossner MJ; Wehr MC
Biosensors (Basel); 2022 Dec; 13(1):. PubMed ID: 36671883
[TBL] [Abstract][Full Text] [Related]
38. Residency time of agonists does not affect the stability of GPCR-arrestin complexes.
Mösslein N; Pohle LG; Fuss A; Bünemann M; Krasel C
Br J Pharmacol; 2022 Aug; 179(16):4107-4116. PubMed ID: 35352338
[TBL] [Abstract][Full Text] [Related]
39. Kappa opioid receptor screen with the Tango beta-arrestin recruitment technology and characterization of hits with second-messenger assays.
Doucette C; Vedvik K; Koepnick E; Bergsma A; Thomson B; Turek-Etienne TC
J Biomol Screen; 2009 Apr; 14(4):381-94. PubMed ID: 19403921
[TBL] [Abstract][Full Text] [Related]
40. Arrestin recruitment and signaling by G protein-coupled receptor heteromers.
Mores KL; Cassell RJ; van Rijn RM
Neuropharmacology; 2019 Jul; 152():15-21. PubMed ID: 30419245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
